← Back to Clinical Trials
Recruiting NCT06153121

NCT06153121 Validity of an Upper Extremity Physical Performance Test Battery in Healthy Athletes

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06153121
Status Recruiting
Phase
Sponsor University Ghent
Condition Athletic Injuries
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-11-22
Primary Completion 2029-11

Eligibility & Interventions

Sex All sexes
Min Age 12 Years
Max Age 40 Years
Study Type INTERVENTIONAL
Interventions
Physical performance test - Closed Kinetic Chain Upper Extremity Stability Test (CKCUEST)Physical performance test - modified Closed Kinetic Chain Upper Extremity Stability Test (m-CKCUEST)Physical performance test - Seated Seated Single Arm Shot Put Test (SSASPT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 200 participants in total. It began in 2023-11-22 with a primary completion date of 2029-11.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

This project comprises two studies; a cross-sectional study and a prospective study. 1. The cross-sectional study aims to develop and validate a new sport-specific test battery (PROMs, analytical and physical performance tests) in healthy tennis players and swimmers.The construct validity of this upper extremity test battery will be examined through two different methods. 1. Firstly, the performance on the test battery will be correlated to sport performance (sprint time at 100m freestyle in swimming and serve speed/accuracy in tennis) 2. Secondly, the correlation between test battery performance and upper limb/trunk kinematics in a tennis serve (measured via inertial measurement units (IMUs)) will be examined. 2. In the prospective study, the predictive validity of the test battery will be evaluated. Healthy swimmers and tennis players will be tested at baseline using the same test battery as mentioned above. The athletes will be followed for one year and new injuries will be recorded via a weekly questionnaire. Performance on the test battery will be associated with the incidence of musculoskeletal injuries.

Eligibility Criteria

Inclusion Criteria: * In good general health * Play tennis or swim competitively, at least 3 hours per week (training + competition) Exclusion Criteria: * History of shoulder dislocation in dominant and/or nondominant shoulder * History of upper extremity surgery * At the moment of participation, participants should not report a substantial injury (defined by the Oslo Sports Trauma Research Centre questionnaire on health problems) in the past two months. A substantial injury is defined as a moderate or severe reduction in training volume or reduction in sports performance or complete inability to participate in sport as substantial injuries and illnesses. * Neurological symptoms in any extremity * Suffering from a systemic disease (such as diabetes, lupus, arthrosis,.. )

Contact & Investigator

Central Contact

Jasper Stubbe

✉ jasper.stubbe@hotmail.be

📞 09 332 26 33

Principal Investigator

Ann Cools

PRINCIPAL INVESTIGATOR

University Ghent

Frequently Asked Questions

Who can join the NCT06153121 clinical trial?

This trial is open to participants of all sexes, aged 12 Years or older, up to 40 Years, studying Athletic Injuries. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06153121 currently recruiting?

Yes, NCT06153121 is actively recruiting participants. Contact the research team at jasper.stubbe@hotmail.be for enrollment information.

Where is the NCT06153121 trial being conducted?

This trial is being conducted at Ghent, Belgium.

Who is sponsoring the NCT06153121 clinical trial?

NCT06153121 is sponsored by University Ghent. The principal investigator is Ann Cools at University Ghent. The trial plans to enroll 200 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology